Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: Opportunities and challenges

Endocrine-Related Cancer

Volumn 18, Issue 1, 2011, Pages

  Hay, Debbie L ^a   Walker, Christopher S ^a   Poyner, David R ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CHEMOKINE RECEPTOR CXCR7; MEMBRANE PROTEIN; PROADRENOMEDULLIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ADRENAL CORTEX CARCINOMA; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; BINDING AFFINITY; BREAST CANCER; CANCER THERAPY; ENDOCRINE TUMOR; ENDOMETRIUM CANCER; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOPHYSIS ADENOMA; INSULINOMA; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; LYMPHANGIOGENESIS; NONHUMAN; NOTE; OVARY CANCER; PANCREAS CANCER; PHEOCHROMOCYTOMA; PROLACTINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; THYROID CANCER; TUMOR GROWTH; TUMOR VOLUME;

ADRENOMEDULLIN; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; NEOPLASMS; RECEPTOR ACTIVITY-MODIFYING PROTEINS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 79251472138     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0244     Document Type: Note

References (113)

1. Albertin G, Forneris M, Aragona F & Nussdorfer GG 2001 Expression of adrenomedullin and its receptors in the human adrenal cortex and aldosteronomas. International Journal of Molecular Medicine 8 423-426.
2. Albertin G, Carraro G, Petrelli L, Guidolin D, Neri G & Nussdorfer GG 2005 Endothelin-1 and adrenomedullin enhance the growth of human adrenocortical carcinoma-derived SW-13 cell line by stimulating proliferation and inhibiting apoptosis. International Journal of Molecular Medicine 15 469-474.
3. Albertin G, Sorato E, Oselladore B, Mascarin A, Tortorella C & Guidolin D 2010 Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells. International Journal of Molecular Medicine 26 289-294. (doi:10.3892/ijmm-00000464)
4. Ando K & Fujita T 2003 Lessons from the adrenomedullin knockout mouse. Regulatory Peptides 112 185-188. (doi:10.1016/S0167-0115(03)00038-7)
5. Autelitano DJ & Tang F 1999 Co-expression of preproadrenomedullin with a putative adrenomedullin receptor gene in vascular smooth muscle. Clinical Science 96 493-498. (doi:10.1042/CS19980311)
6. Bailey RJ & Hay DL 2006 Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27 1367-1375. (doi:10.1016/j.peptides.2005.11.014)
7. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M & Bachelerie F 2005 The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. Journal of Biological Chemistry 280 35760-35766. (doi:10.1074/jbc.M508234200)
8. Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM et al. 2008 Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Oncogene 27 506-518. (doi:10.1038/sj.onc.1210656)
9. Bouschet T, Martin S & Henley JM 2005 Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. Journal of Cell Science 118 4709-4720. (doi:10.1242/jcs.02598)
10. Brain SD & Grant AD 2004 Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiological Reviews 84 903-934. (doi:10.1152/physrev.00037.2003)
11. Brekhman V, Lugassie J, Zaffryar-Eilot S, Sabo E, Kessler O, Smith V, Golding H & Neufeld G 2010 Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2. FASEB Journal [in press]. (doi:10.1096/fj.10-162677)
12. Buyukberber S, Sari I, Camci C, Buyukberber NM, Sevinc A & Turk HM 2007 Adrenomedullin expression does not correlate with survival in lung cancer. Medical Oncology 24 245-249. (doi:10.1007/BF02698047)
13. Calvo A, Abasolo I, Jimenez N, Wang Z & Montuenga L 2002 Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma. Microscopy Research and Technique 57 98-104. (doi:10.1002/jemt.10056)
14. Caron KM & Smithies O 2001 Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. PNAS 98 615-619. (doi:10.1073/pnas.021548898)
15. Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S & Smith DM 2000 CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. British Journal of Pharmacology 130 189-195. (doi:10.1038/sj.bjp.0702975) (Pubitemid 30248444)
16. Choksi T, Hay DL, Legon S, Poyner DR, Hagner S, Bloom SR & Smith DM 2002 Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. British Journal of Pharmacology 136 784-792. (doi:10.1038/sj.bjp.0704761)
17. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N & Sexton PM 2003 Novel receptor partners and function of receptor activity-modifying proteins. Journal of Biological Chemistry 278 3293-3297. (doi:10.1074/jbc.C200629200)
18. Copple BL, Bustamante JJ, Welch TP, Kim ND & Moon JO 2009 Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes. Liver International 29 1010-1021. (doi:10.1111/j.1478-3231. 2009.02015.x)
19. Dackor RT, Fritz-Six K, Dunworth WP, Gibbons CL, Smithies O & Caron KM 2006 Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Molecular and Cellular Biology 26 2511-2518. (doi:10.1128/MCB.26.7.2511-2518.2006)
20. Dackor R, Fritz-Six K, Smithies O & Caron K 2007 Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. Journal of Biological Chemistry 282 18094-18099. (doi:10.1074/jbc.M703544200)
21. Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, Fina F, Salas S, Muracciole X, Mancini J et al. 2009 Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. International Journal of Cancer 125 2307-2315. (doi:10.1002/ijc.24568)
22. Doods H, Arndt K, Rudolf K & Just S 2007 CGRP antagonists: unravelling the role of CGRP in migraine. Trends in Pharmacological Sciences 28 580-587. (doi:10.1016/j.tips.2007.10.005)
23. Durham PL & Vause CV 2010 Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs 24 539-548. (doi:10.2165/11534920-000000000-00000)
24. Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J & Edvinsson L 2010 Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169 683-696. (doi:10.1016/j.neuroscience.2010.05.016)
25. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L & Boudouresque F 2004 Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. International Journal of Cancer 108 797-804. (doi:10.1002/ijc.11663) (Pubitemid 38112605)
26. Forneris M, Gottardo L, Albertin G, Malendowicz LK & Nussdorfer GG 2001 Expression and function of adrenomedullin and its receptors in Conn's adenoma cells. International Journal of Molecular Medicine 8 675-679.
27. Fritz-Six KL, Dunworth WP, Li M & Caron KM 2008 Adrenomedullin signaling is necessary for murine lymphatic vascular development. Journal of Clinical Investigation 118 40-50. (doi:10.1172/JCI33302)
28. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R et al. 2000 Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Molecular Endocrinology 14 848-862. (doi:10.1210/me.14.6.848)
29. Garcia MA, Martin-Santamaria S, de Pascual-Teresa B, Ramos A, Julian M & Martinez A 2006 Adrenomedullin: a new and promising target for drug discovery. Expert Opinion on Therapeutic Targets 10 303-317. (doi:10.1517/14728222.10.2.303)
30. Guidolin D, Albertin G, Spinazzi R, Sorato E, Mascarin A, Cavallo D, Antonello M & Ribatti D 2008 Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2. Peptides 29 2013-2023. (doi:10.1016/j.peptides.2008.07.009)
31. ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, Lepre CA, Garcia-Guzman M & Moore JM 2010 Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 8 1083-1093. (doi:10.1016/j.str.2010.05.014)
32. Hay DL, Howitt SG, Conner AC, Doods H, Schindler M & Poyner DR 2002 A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells. British Journal of Pharmacology 137 80-86. (doi:10.1038/sj.bjp.0704844)
33. 8-37 and BIBN4096BS. British Journal of Pharmacology 140 477-486. (doi:10.1038/sj.bjp.0705472)
34. Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, Kawate H, Iinuma N, Yoshizawa T, Koyama T, Fukuchi J, Iimuro S, Moriyama N et al. 2008 The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. Journal of Clinical Investigation 118 29-39. (doi:10.1172/JCI33022)
35. Iimuro S, Shindo T, Moriyama N, Amaki T, Niu P, Takeda N, Iwata H, Zhang Y, Ebihara A & Nagai R 2004 Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circulation Research 95 415-423. (doi:10.1161/01.RES. 0000138018.61065.d1)
36. Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, Kobayashi T, Shindo M, Higashino F, Katoh H, Asaka M et al. 2003 Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 22 1238-1242. (doi:10.1038/sj.onc.1206207)
37. Iwase T, Nagaya N, Fujii T, Itoh T, Ishibashi-Ueda H, Yamagishi M, Miyatake K, Matsumoto T, Kitamura S & Kangawa K 2005 Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation 111 356-362. (doi:10.1161/01.CIR.0000153352.29335.B9)
38. Jin D, Harada K, Ohnishi S, Yamahara K, Kangawa K & Nagaya N 2008 Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. Cardiovascular Research 80 339-345. (doi:10.1093/cvr/cvn228)
39. Kaafarani I, Fernandez-Sauze S, Berenguer C, Chinot O, Delfino C, Dussert C, Metellus P, Boudouresque F Mabrouk K, Grisoli F et al. 2009 Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice. FASEB Journal 23 3424-3435. (doi:10.1096/fj.08-127852)
40. Kahn ML 2008 Blood is thicker than lymph. Journal of Clinical Investigation 118 23-26. (doi:10.1172/JCI34485)
41. Kamohara M, Matsuo A, Takasaki J, Kohda M, Matsumoto M, Matsumoto S, Soga T, Hiyama H, Kobori M & Katou M 2005 Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides. Biochemical and Biophysical Research Communications 330 1146-1152. (doi:10.1016/j.bbrc.2005.03.088)
42. Kapas S & Clark AJ 1995 Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochemical and Biophysical Research Communications 217 832-838. (doi:10.1006/bbrc.1995.2847)
43. Kapas S, Catt KJ & Clark AJ 1995 Cloning and expression of cDNA encoding a rat adrenomedullin receptor. Journal of Biological Chemistry 270 25344-25347. (doi:10.1074/jbc.270.43.25344)
44. Kawanami Y, Morimoto Y, Kim H, Nakamura T, Machida K, Kido T, Asonuma E, Yatera K, Yoshii C & Kido M 2009 Calcitonin gene-related peptide stimulates proliferation of alveolar epithelial cells. Respiratory Research 10 8. (doi:10.1186/1465-9921-10-8)
45. Kawase T, Okuda K & Burns DM 2005 Immature osteoblastic MG63 cells possess two calcitonin generelated peptide receptor subtypes that respond differently to [Cys(Acm)(2,7)] calcitonin gene-related peptide and CGRP(8-37). American Journal of Physiology. Cell Physiology 289 C811-C818. (doi:10.1152/ajpcell.00504.2004)
46. Keleg S, Kayed H, Jiang X, Penzel R, Giese T, Buchler MW, Friess H & Kleeff J 2007 Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. International Journal of Cancer 121 21-32. (doi:10.1002/ijc.22596) (Pubitemid 46759489)
47. Kelley MJ, Snider RH, Becker KL & Johnson BE 1994 Small cell lung carcinoma cell lines express mRNA for calcitonin and α- and β-calcitonin gene related peptides. Cancer Letters 81 19-25. (doi:10.1016/0304-3835(94)90159-7)
48. Kenakin T 2008 Functional assays as prismatic views of drug activity: relevance to new drug discovery. Journal of Receptors and Signal Transduction Research 28 109-125. (doi:10.1080/10799890801946318)
49. Kennedy SP, Sun D, Oleynek JJ, Hoth CF, Kong J & Hill RJ 1998 Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochemical and Biophysical Research Communications 244 832-837. (doi:10.1006/bbrc.1998.8349)
50. Knerr I, Schuster S, Nomikos P, Buchfelder M, Dotsch J, Schoof E, Fahlbusch R & Rascher W 2001 Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumours in humans. Neuropathology and Applied Neurobiology 27 215-222. (doi:10.1046/j.0305-1846. 2001.00324.x)
51. Ladoux A & Frelin C 2000 Coordinated up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier. Journal of Biological Chemistry 275 39914-39919. (doi:10.1074/jbc.M006512200)
52. Letizia C, De Toma G, Cerci S, Massa R, Coassin S, Subioli S, Scuro L & De Ciocchis A 1998 Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure. Blood Pressure 7 19-23. (doi:10.1080/080370598437529)
53. Letizia C, Tamburrano G, Alo P, Paoloni A, Caliumi C, Marinoni E, di Iorio R & d'Erasmo E 2001 Adrenomedullin, a new peptide, in patients with insulinoma. European Journal of Endocrinology 144 517-520. (doi:10.1530/eje.0. 1440517)
54. Li Z, Takeuchi S, Ohara N & Maruo T 2003 Paradoxically abundant expression of Bcl-2 and adrenomedullin in invasive cervical squamous carcinoma. International Journal of Clinical Oncology 8 83-89. (doi:10.1007/s101470300015)
55. Liu J, Butzow R, Hyden-Granskog C & Voutilainen R 2009 Expression of adrenomedullin in human ovaries, ovarian sex cord-stromal tumors and cultured granulosa-luteal cells. Gynecological Endocrinology 25 96-103. (doi:10.1080/09513590802488412)
56. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM & Cuttitta F 1995 Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136 4099-4105. (doi:10.1210/en.136.9.4099)
57. Martinez A, Miller MJ, Catt KJ & Cuttitta F 1997 Adrenomedullin receptor expression in human lung and in pulmonary tumors. Journal of Histochemistry and Cytochemistry 45 159-164.
58. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, Garayoa M, Pio R, Moody T, Stetler-Stevenson WG, Kleinman HK et al. 2002 The effects of adrenomedullin overexpression in breast tumor cells. Journal of the National Cancer Institute 94 1226-1237. (doi:10.1093/jnci/94.16.1226)
59. Martinez A, Zudaire E, Portal-Nunez S, Guedez L, Libutti SK, Stetler-Stevenson WG & Cuttitta F 2004 Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Research 64 6489-6494. (doi:10.1158/0008-5472.CAN-04- 0103)
60. Mazzocchi G, Malendowicz LK, Ziolkowska A, Spinazzi R, Rebuffat P, Aragona F, Ferrazzi E, Parnigotto PP & Nussdorfer GG 2004 Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates. International Journal of Oncology 25 1781-1787.
61. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG & Foord SM 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 333-339. (doi:10.1038/30666)
62. Michelsen J, Thiesson H, Walter S, Ottosen PD, Skott O & Jensen BL 2006 Tissue expression and plasma levels of adrenomedullin in renal cancer patients. Clinical Science 111 61-70. (doi:10.1042/CS20060030)
63. Michishita M, Minegishi T, Abe K, Kangawa K, Kojima M & Ibuki Y 1999 Expression of adrenomedullin in the endometriumof the human uterus. Obstetrics & Gynecology 93 66-70.
64. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T & Cuttitta F 1996 Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. Journal of Biological Chemistry 271 23345-23351. (doi:10.1074/jbc.271.38.23345)
65. Miyashita K, Itoh H, Sawada N, Fukunaga Y, Sone M, Yamahara K, Yurugi-Kobayashi T, Park K & Nakao K 2003a Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Letters 544 86-92. (doi:10.1016/S0014-5793(03)00484-8)
66. Miyashita K, Itoh H, Sawada N, Fukunaga Y, Sone M, Yamahara K, Yurugi T & Nakao K 2003b Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertension Research 26 (Suppl) S93-S98. (doi:10.1291/hypres.26.S93)
67. Nagakawa O, Ogasawara M, Fujii H, Murakami K, Murata J, Fuse H & Saiki I 1998 Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells. Cancer Letters 133 27-33. (doi:10.1016/S0304-3835(98) 00186-4)
68. Nagakawa O, Ogasawara M, Murata J, Fuse H & Saiki I 2001 Effect of prostatic neuropeptides on migration of prostate cancer cell lines. International Journal of Urology 8 65-70. (doi:10.1046/j.1442-2042.2001.00250.x)
69. Nakamura M, Han B, Nunobiki O & Kakudo K 2006 Adrenomedullin: a tumor progression factor via angiogenic control. Current Cancer Drug Targets 6 635-643. (doi:10.2174/156800906778742442)
70. Nakata T, Seki N, Miwa S, Kobayashi A, Soeda J, Nimura Y, Kawasaki S & Miyagawa S 2008 Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis? Hepatogastroenterology 55 865-872.
71. Nikitenko LL, Brown NS, Smith DM, MacKenzie IZ, Bicknell R & Rees MC 2001 Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. Molecular Human Reproduction 7 655-664. (doi:10.1093/molehr/7.7.655)
72. Nikitenko LL, Fox SB, Kehoe S, Rees MC & Bicknell R 2006 Adrenomedullin and tumour angiogenesis. British Journal of Cancer 94 1-7. (doi:10.1038/sj.bjc.6602832)
73. Oehler MK, Hague S, Rees MC & Bicknell R 2002 Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 21 2815-2821. (doi:10.1038/sj.onc.1205374)
74. Oehler MK, Fischer DC, Orlowska-Volk M, Herrle F, Kieback DG, Rees MC & Bicknell R 2003 Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. British Journal of Cancer 89 1927-1933. (doi:10.1038/sj.bjc.6601397)
75. Ouafik L, Berenguer-Daize C & Berthois Y 2009 Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway. Cellular Signalling 21 597-608. (doi:10.1016/j.cellsig.2009.01.001)
76. Pacini F, Basolo F, Elisei R, Fugazzola L, Cola A & Pinchera A 1991 Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. American Journal of Clinical Pathology 95 300-308.
77. Pacini F, Fugazzola L, Basolo F, Elisei R & Pinchera A 1992 Expression of calcitonin gene-related peptide in medullary thyroid cancer. Journal of Endocrinological Investigation 15 539-542.
78. Papantoniou V, Tsiouris S, Sotiropoulou M, Valsamaki P, Koutsikos J, Ptohis N, Dimitrakakis C, Sotiropoulou E, Melissinou M, Nakopoulou L et al. 2007 The potential role of calcitonin gene-related peptide (CGRP) in breast carcinogenesis and its correlation with 99mTc-(V)DMSA scintimammography. American Journal of Clinical Oncology 30 420-427. (doi:10.1097/COC. 0b013e3180337792)
79. Papantoniou V, Sotiropoulou E, Valsamaki P, Tsaroucha A, Sotiropoulou M, Ptohis N, Stipsanelli A, Dimitrakakis K, Marinopoulos S, Tsiouris S et al. 2010 Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC+DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade. BreastCancer [in press]. (doi:10.1007/s12282-009- 0192-y)
80. Park HC, Seong J, An JH, Kim J, Kim UJ & Lee BW 2005 Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion. International Journal of Radiation Oncology, Biology, Physics 61 1523-1534. (doi:10.1016/j.ijrobp.2004.12.070)
81. Park SC, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ et al. 2008 Hypoxiainducible adrenomedullin accelerates hepatocellular carcinoma cell growth. Cancer Letters 271 314-322. (doi:10.1016/j.canlet.2008.06.019)
82. Pavel ME, Hoppe S, Papadopoulos T, Linder V, Mohr B, Hahn EG, Lohmann T & Schuppan D 2006 Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas. Hormone and Metabolic Research 38 112-118. (doi:10.1055/s-2006-925129)
83. Pearson LJ, Yandle TG, Nicholls MG & Evans JJ 2009 Intermedin (adrenomedullin-2): a potential protective role in human aortic endothelial cells. Cellular Physiology and Biochemistry 23 97-108. (doi:10.1159/000204098)
84. Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI, Gries B, Rafiq A, Faulhammer P, Goldenberg A et al. 2009 Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. American Journal of Physiology. Lung Cellular and Molecular Physiology 297 L837-L845. (doi:10.1152/ajplung.90608.2008)
85. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA & Foord SM 2002 International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacological Reviews 54 233-246. (doi:10.1124/pr.54.2. 233)
86. Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM & Hay DL 2008 Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Molecular Pharmacology 74 1059-1071. (doi:10.1124/mol.108. 047142)
87. Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM & Logsdon CD 2007 Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Research 67 2666-2675. (doi:10.1158/0008-5472.CAN-06- 3362)
88. Ramachandran V, Arumugam T, Langley R, Hwang RF, Vivas-Mejia P, Sood AK, Lopez-Berestein G & Logsdon CD 2009 The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS ONE 4 e7502. (doi:10.1371/journal.pone.0007502)
89. Robinson SD, Aitken JF, Bailey RJ, Poyner DR & Hay DL 2009 Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3. Journal of Pharmacology and Experimental Therapeutics 331 513-521. (doi:10.1124/jpet.109. 156448)
90. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM & Ouafik L 2001 Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Research 61 1196-1206.
91. Roh J, Chang CL, Bhalla A, Klein C & Hsu SY 2004 Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. Journal of Biological Chemistry 279 7264-7274. (doi:10.1074/jbc. M305332200)
92. Roldos V, Martin-Santamaria S, Julian M, Martinez A, Choulier L, Altschuh D, de Pascual-Teresa B & Ramos A 2008 Small-molecule negative modulators of adrenomedullin: design, synthesis, and 3D-QSAR study. ChemMedChem 3 1345-1355. (doi:10.1002/cmdc.200800066)
93. Rubinstein C, Fletcher DR, Shulkes A & Hardy KJ 1992 Elevated plasma calcitonin gene-related peptide and the symptoms associated with medullary thyroid cancer. Australian and New Zealand Journal of Surgery 62 892-896. (doi:10.1111/j.1445-2197.1992.tb06945.x)
94. Salvatore CA, Hershey JC, Corcoran HA, Fay JF, Johnston VK, Moore EL, Mosser SD, Burgey CS, Paone DV, Shaw AW et al. 2008 Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2- trifluoroethyl)azepan-3- yl]-4-(2-oxo-2,3-dihydro-1Himidazo[ 4,5-b]pyridin-1-yl)piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. Journal of Pharmacology and Experimental Therapeutics 324 416-421. (doi:10.1124/jpet.107.130344)
95. Schwarz N, Renshaw D, Kapas S & Hinson JP 2006 Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells. Journal of Endocrinology 190 505-514. (doi:10.1677/joe.1.06806)
96. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, Wang Y, Imai Y, Ebihara A, Kuwaki T, Ju KH et al. 2001 Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104 1964-1971. (doi:10.1161/hc4101.097111)
97. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M et al. 2007 Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. PNAS 104 14759-14764. (doi:10.1073/pnas.0702229104)
98. Smith RS Jr, Gao L, Bledsoe G, Chao L & Chao J 2009 Intermedin is a new angiogenic growth factor. American Journal of Physiology. Heart and Circulatory Physiology 297 H1040-H1047. (doi:10.1152/ajpheart.00404.2009)
99. Song JQ, Teng X, Cai Y, Tang CS & Qi YF 2009 Activation of Akt/GSK-3β signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14 1299-1307. (doi:10.1007/s10495-009-0398-7)
100. Suzuki K, Kobayashi Y & Morita T 2006 Serum calcitonin gene-related peptide levels in untreated prostate cancer patients. International Journal of Urology 13 781-784. (doi:10.1111/j.1442-2042.2006.01402.x)
101. Suzuki K, Kobayashi Y & Morita T 2009 Significance of serum calcitonin gene-related peptide levels in prostate cancer patients receiving hormonal therapy. Urologia Internationalis 82 291-295. (doi:10.1159/000209360)
102. Takei Y, Hyodo S, Katafuchi T & Minamino N 2004 Novel fish-derived adrenomedullin in mammals: structure and possible function. Peptides 25 1643-1656. (doi:10.1016/j.peptides.2004.06.026)
103. Thouennon E, Pierre A, Tanguy Y, Guillemot J, Manecka DL, Guerin M, Ouafik L, Muresan M, Klein M, Bertherat J et al. 2010 Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival. Endocrine-Related Cancer 17 637-651. (doi:10.1677/ERC-10-0109)
104. Toda M, Suzuki T, Hosono K, Hayashi I, Hashiba S, Onuma Y, Amano H, Kurihara Y, Kurihara H, Okamoto H et al. 2008 Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. PNAS 105 13550-13555. (doi:10.1073/pnas.0800767105)
105. Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga N, Akino T, Kondo T, Miseki T, Nakagawa K, Shindoh M et al. 2010 Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization. International Journal of Oncology 36 1379-1386. (doi:10.3892/ijo-00000622)
106. Wacnik PW, Baker CM, Herron MJ, Kren BT, Blazar BR, Wilcox GL, Hordinsky MK, Beitz AJ & Ericson ME 2005 Tumor-induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors. Pain 115 95-106. (doi:10.1016/j.pain.2005.02.024)
107. Walker CS, Conner AC, Poyner DR & Hay DL 2010 Regulation of signal transduction by calcitonin generelated peptide receptors. Trends in Pharmacological Sciences 31 476-483. (doi:10.1016/j.tips.2010.06.006)
108. Zajac JD, Penschow J, Mason T, Tregear G, Coghlan J & Martin TJ 1986 Identification of calcitonin and calcitonin gene-related peptide messenger ribonucleic acid in medullary thyroid carcinomas by hybridization histochemistry. Journal of Clinical Endocrinology and Metabolism 62 1037-1043. (doi:10.1210/jcem-62-5-1037)
109. Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP & McDermott BJ 2006 Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. Journal of Pharmacology and Experimental Therapeutics 316 1269-1281. (doi:10.1124/jpet.105.092783)
110. Zheng S, Li W, Xu M, Bai X, Zhou Z, Han JY, Shyy JY & Wang X 2010 Calcitonin gene-related peptide promotes angiogenesis via AMP-activated protein kinase. American Journal of Physiology. Cell Physiology [in press]. (doi:10.1152/ajpcell.00173.2010)
111. Zudaire E, Cuttitta F & Martinez A 2003a Regulation of pancreatic physiology by adrenomedullin and its binding protein. Regulatory Peptides 112 121-130. (doi:10.1016/S0167-0115(03)00030-2)
112. Zudaire E, Martinez A & Cuttitta F 2003b Adrenomedullin and cancer. Regulatory Peptides 112 175-183. (doi:10.1016/S0167-0115(03)00037-5)
113. Zudaire E, Martinez A, Garayoa M, Pio R, Kaur G, Woolhiser MR, Metcalfe DD, Hook WA, Siraganian RP, Guise TA et al. 2006 Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. American Journal of Pathology 168 280-291. (doi:10.2353/ajpath. 2006.050291)